REGN Regeneron Pharmaceuticals, Inc.

REGN (Regeneron Pharmaceuticals, Inc.) is a US stock trading at $772.11, +0.46% on the day. mdvin's smart-money engine places it in the RUNNING operator phase, with a GRINDER accumulation style. Current conviction is 56/100 and the Buy Score is 82. The active signal is QUIET. It has ignited 1 time(s) in the last 90 sessions, paying off 20% of the time (typical run +2.0%). Reversal/trap risk is graded HIGH. On fundamentals it looks fair value (quality grade A, analyst upside +8.00%).